| Literature DB >> 31662773 |
Aleksandra Shedoeva1, David Leavesley1, Zee Upton1,2, Chen Fan1.
Abstract
Cutaneous wound healing is the process by which skin repairs itself. It is generally accepted that cutaneous wound healing can be divided into 4 phases: haemostasis, inflammation, proliferation, and remodelling. In humans, keratinocytes re-form a functional epidermis (reepithelialization) as rapidly as possible, closing the wound and reestablishing tissue homeostasis. Dermal fibroblasts migrate into the wound bed and proliferate, creating "granulation tissue" rich in extracellular matrix proteins and supporting the growth of new blood vessels. Ultimately, this is remodelled over an extended period, returning the injured tissue to a state similar to that before injury. Dysregulation in any phase of the wound healing cascade delays healing and may result in various skin pathologies, including nonhealing, or chronic ulceration. Indigenous and traditional medicines make extensive use of natural products and derivatives of natural products and provide more than half of all medicines consumed today throughout the world. Recognising the important role traditional medicine continues to play, we have undertaken an extensive survey of literature reporting the use of medical plants and plant-based products for cutaneous wounds. We describe the active ingredients, bioactivities, clinical uses, formulations, methods of preparation, and clinical value of 36 medical plant species. Several species stand out, including Centella asiatica, Curcuma longa, and Paeonia suffruticosa, which are popular wound healing products used by several cultures and ethnic groups. The popularity and evidence of continued use clearly indicates that there are still lessons to be learned from traditional practices. Hidden in the myriad of natural products and derivatives from natural products are undescribed reagents, unexplored combinations, and adjunct compounds that could have a place in the contemporary therapeutic inventory.Entities:
Year: 2019 PMID: 31662773 PMCID: PMC6778887 DOI: 10.1155/2019/2684108
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Wound healing cascade—humans. The wound healing process is an orderly sequence of overlapping, interacting processes commonly categorised into four distinct phases: coagulation, inflammation, proliferation/migration/reepithelialization/granulation, and remodelling/maturation. (1) Coagulation: a clot is formed, providing a temporary barrier to fluid loss and pathogen entry, restores haemostasis; acts as a reservoir of bioactive factors and antimicrobials; provides provisional ECM which supports immune cell infiltration and migration; and initiates tissue repair pathways. (2) Inflammation: damage-associated molecular patterns, free radicals, and reactive molecular species are signals to recruit immune cells; increased blood vessel leakiness; release of antimicrobial species; infiltrating immune cells secretes amplifying alarmin (also known as DAMPs) signals; and activation of keratinocytes and fibroblasts. (3) Proliferation/migration/reepithelialization/granulation: migration and proliferation of keratinocytes, fibroblasts, endothelia; resolution of inflammation; collagen/ECM synthesis; decreased vessel permeability; new capillary and lymphatic vessel angiogenesis; reepithelialization; and de novo formation of granulation tissue. (4) Remodelling/maturation: collagen/ECM turnover (synthesis and degradation); ECM reorganisation and realignment; ECM contraction; endothelia and fibroblast apoptosis; repigmentation.
Figure 2Nonhealing/chronic wounds—humans. The orderly sequence of overlapping, interacting wound healing processes fails to progress in chronic wounds, frequently due to failure to resolve inflammation. (1) Coagulation: usually unaffected. (2) Inflammation: damage-associated molecular patterns, free radicals, and reactive molecular species; high pH; functional activation of proteases, senescence of keratinocytes, and fibroblasts (vessel permeability sustained-aetiology specific). (3) Proliferation/migration: initiation of de novo granulation tissue formation; failure to sustain proliferation; failure to initiate angiogenesis; failure of keratinocytes to migrate and reepithelialise (failure of wound closure); failure to resolve inflammation; and failure to accumulate ECM. (4) Remodelling/maturation: fails to initiate reorganisation and maturation of ECM.
Summary of the medicinal plants used in wound healing.
| Botanical name | Traditional name | Plant family | Active ingredients | Part used | Type of extract | Assessment methods | Bioactivities | Clinical use | Formulation | Commercial product |
|---|---|---|---|---|---|---|---|---|---|---|
|
| Lu Hui | Asphodelaceae | Acemannan [ | Leaves | Ethanol | Punch biopsy wounds in Sprague-Dawley rats [ | Immunomodulatory [ | Wound healing [ | Gel [ | Aloe vera gel |
|
| Niu Bang Zi | Asteraceae | Arctigenin [ | Leaves | No extraction, whole leaves | Human burn wounds [ | Anticancer [ | Acne vulgaris [ | Ointment [ | Not available |
|
| Huang Qi | Fabaceae | Astragaloside IV [ | Roots | Aqueous |
| Anti-inflammatory [ | Diabetic foot ulcer [ | Herbal drink [ | Not available |
|
| Bai Lian | Vitaceae | Catechins [ | Root tuber | Ethanol | Cutaneous scald injury in rats [ | Anticancer [ | Antipyretic detoxicate [ | Wound plaster (Patent: CN105748741A) | Hydrating Moisturizer |
|
| Chuan Xin Lian | Acanthaceae | Andrographolide [ | Leaves | Aqueous | Excision model in albinos Wistar rats [ | Anticancer [ | Dysentery [ | Paste (applied externally), juice (internally) [ | Chuan Xin Lian Nei Zhi Di Wan (穿心莲内酯滴丸) |
|
| Dang Gui | Apiaceae | Ferulic acid [ | Whole plant | Ethanol | Cell line antioxidant activity assay [ | Anticancer [ | Amenorrhea [ | Ointment [ | Dang Gui Shao Yao San (当归芍药散) |
|
| Ai Na Xiang | Asteraceae | L-Borneol [ | Leaves | Violate oil | Excision wound model in mice [ | Antifungal [ | Beriberi [ | Oil | Blumea leaf oil |
|
| Ru Xiang | Burseraceae | Boswellic acids [ | Resin | Dry extract | Rabbit ear hypertrophic scar model of full-thickness scar defect [ | Anticancer [ | Improvement of blood circulation [ | Spray [ | Frankincense oil |
|
| Su Mu | Fabaceae | Brazilin [ | Roots | Ethanolic |
| Antiallergic [ | Improvement of blood circulation [ | Tablets | Lukol™, Vicco Vajradanti™ |
|
| Jin Zhan Ju | Asteraceae | Esculetin [ | Flower | Hexane and ethanol | Scratch assay [ | Antibacterial [ | Burns [ | Topical spray [ | Calendula Herbal-Extract Toner |
|
| Cha Shu | Theaceae | Epcatechin-3-gallate [ | Leaves | Methanol |
| Antiaging [ | Angina pectoris [ | Oil | Tea tree oil |
|
| Hong Hua | Asteraceae | Hydroxysafflor yellow A [ | Seeds | Reflux | Antioxidant enzyme assay in zebrafish [ | Anti-inflammatory [ | Blood stasis [ | Oil | Safflower oil (红花油) |
|
| Qing Xiang | Amaranthaceae | Celosin I [ | Leaves | Ethanol | Rat burn wound model [ | Antidiabetic [ | Skin sores [ | Poultice of stems and leaves (topically) [ | Not available |
|
| Ji Xue Cao | Apiaceae | Asiaticoside [ | Aerial parts | Hexane, ethyl acetate, methanol, and water | Incision and partial-thickness burn wound models in rats [ | Anti-inflammatory [ | Wounds [ | Oral form (tablets, drops) | Madecassol® [ |
|
| Rou Gui | Lauraceae | Cinnamaldehyde [ | Bark | Volatile oil |
| Anticancer [ | Analgesia [ | Oil | Cinnamon cassia oil |
|
| Mo Yao | Burseraceae | Furanoeudesma-1,3-diene [ | Leaves and resin | Dry extract | Excision wound model in diabetic rats [ | Analgesic [ | Gastrointestinal diseases [ | Oil | Myrrh essential oil |
|
| Jiang Huang | Zingiberaceae | Curcuminoids [ | Rhizomes | Nanosuspension | Antioxidant analysis [ | Antibacterial [ | Digestive diseases [ | Capsules [ | Kordel's Theracurmin™ |
|
| Yuan Hua | Thymelaeaceae | Daphnodorin B [ | Flower | Aqueous | Human wounds from anal fistula therapy [ | Anti-inflammatory [ | Coughs [ | Not available | Not available |
|
| Ke Teng | Fabaceae | Tannin [ | Stem skin and seeds | Ethanol | Acetic acid-induced mouse writhing experiment [ | Antibacterial [ | Aging [ | Not available | Not available |
|
| Zhu Jin | Malvaceae | Anthocyanins [ | Flower | Ethanol | Excision, incision and dead space wound models in rats [ | Antibacterial [ | Antitumour [ | Powder | Lustrous Henna® Shampoo powder |
|
| Ling Zhi | Ganodermataceae | Ganoderma lucidum polysaccharide [ | Fruiting body | Aqueous | Excision wound model in diabetic rats [ | Antihyperlipidemic [ | Cancer [ | Not available | Ganoderma lucidum spores powder capsules |
|
| Chuan Xiong | Apiaceae | Ferulic acid [ | Rhizome | Extracted by hydrodistillation | Hypertrophic scar rabbit model [ | Antiatherosclerotic [ | Headache [ | Not available | Chuanxiong chatiao Wan (川芎茶调丸) |
|
| Jin Yin Hua | Caprifoliaceae | Biflavonoids [ | Flowering aerial parts | Ethanol | Rat excision wound model [ | Anticancer [ | Infectious diseases [ | Essential oils [ | Not available |
|
| Mu Dan | Paeoniaceae | Suffruticosides A, B, C, and D [ | Root bark | Water, ethanol-water |
| Antidiabetic [ | Genital diseases [ | Ointment | Winvivo (Puji) ointment |
|
| Ren Shen | Araliaceae | Ginsenosides Rb1, Rb2, Rc, and Rd [ | Leaves | Ethanol | Laser burn and excision wounds models in mice [ | Antiaging [ | Wound healing [ | Not available | Ginseng Strong 200 mg |
|
| San Qi | Araliaceae | Notoginsenoside Ft1 [ | Leaves, flower, roots, and rhizome | Steamed extraction |
| Angiogenesis-stimulatory [ | Trauma [ | Powder on wound | San Qi Fen (三七粉) |
|
| Hu Zhang | Polygonaceae | Emodin [ | Roots | Ethanol | Full-thickness excision wounds in rats [ | Antiaging [ | Hepatitis [ | Capsules | Resveratrol supplement |
|
| Zi Cao | Boraginaceae | Arnebin-1 [ | Roots | Frozen and ground | Apoptotic effects against murine primary peritoneal macrophages [ | Antiangiogenic [ | Wounds [ | Oil formulations, gel [ | Burt's bee Res-Q ointment (神奇紫草膏) |
|
| Da Huang | Polygonaceae | Emodin [ | Roots | Ethanol | Rat excisional wound model [ | Antibacterial [ | Chronic kidney disease [ | Pills | Dahuang Zhechong Wan (大黄蜇虫丸) |
|
| Hong Jing Tian | Crassulaceae | Gallic acid [ | Rhizome | Ethanol | Rat excision wound model [ | Anticancer [ | Asthma [ | Not available | Not available |
|
| Dan Shen | Lamiaceae | Cryptotanshinone [ | Leaves | Aqueous |
| Anticancer [ | Blood stasis [ | Pills | Compound danshen dripping pills (复方丹参滴丸) |
|
| Di Yu | Rosaceae | Tannins [ | Roots | Ethanol | Burn wound model in mice [ | Antiallergy [ | Burns [ | Oral administration |
|
|
| Ku Shen | Fabaceae | Kushenol [ | Roots | Cellulose column | Human liver LO2 proliferation and viability assay [ | Analgesic [ | Asthma [ | Gel | Kushen gel (苦参凝胶) |
|
| Bai Bu | Stemonaceae | Tuberostemonine N [ | Roots | Methanol | Mouse fibroblast NIH3T3 proliferation assay [ | Antibacterial [ | Insect pests [ | Not available | Not available |
|
| Asteraceae | Kaurenoic acid [ | Leaves | Ethanol |
| Antimicrobial [ | Arthritic painful joints [ | Not available | Not available | |
|
| Hua Jiao | Rutaceae | Afzelin [ | Seed oil | Press extraction | Rat scald wound model [ | Anaesthetic [ | Skin wrinkles [ | Cream | ZANTHALENE® |